Mutual Funds

UTI Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

292.79 -0.34
NAV(₹) as on 8/9/2025

-0.12%
1D

2.75%
1Y

25.10%
3Y

19.34%
5Y

UTI Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.26	Launch Date: 01 Aug 2005
Exit Load: 1% on or before 30D, Nil after 30D	AUM: ₹ 1,118.51 Crs
Lock-in: Nil	Investing Style: Mid Growth
Portfolio Price To Book Value: 7.79	Min. Investment: SIP : ₹ NA Lumpsum : ₹ 5,000.0
Scheme Benchmark: NA
Fund Manager: Kamal Gada

FUND OBJECTIVE

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Equity
as on 31/8/2025		0.65 %		99.35 %

TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.

9.42 %

Cipla Ltd.

5.68 %

Ajanta Pharma Ltd.

5.38 %

Lupin Ltd.

4.57 %

Dr. Reddy's Laboratories Ltd.

4.06 %

Procter & Gamble Health Ltd.

3.99 %

Fortis Healthcare Ltd.

3.79 %

Glenmark Pharmaceuticals Ltd.

3.78 %

Apollo Hospitals Enterprise Ltd.

3.61 %

Alkem Laboratories Ltd.

3.41 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

75.36 %

Hospital & Healthcare Servic

22.52 %

Business Support

1.01 %

Medical Equipment/Supplies/A

0.47 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

Average Maturity

Modified Duration

Yield to Maturity

(in )

5 YEAR HISTORY

Financial Year	2020-21	2021-22	2022-23	2023-24	2024-25
NAV (31/3/2025)	139.38	157.00	143.40	223.40	268.23
Net Assets (Rs Crores)	61,812.63	77,623.29	65,449.87	94,725.87	1,04,203.85
Scheme Returns(%)(Absolute)	76.19	12.06	-8.81	55.54	18.69
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	35/75	50/75	68/76	21/90	5/102

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 13.54 +0.08	11/12/2023	₹ 466.92	-0.32%	-	-	18.93%
Quant Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 15.32 +0.13	17/7/2023	₹ 384.01	-11.92%	-	-	21.95%
HDFC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.33 +0.10	4/10/2023	₹ 1,909.3	9.27%	-	-	33.13%
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 13.92 +-0.04	6/2/2024	₹ 423.51	8.76%	-	-	23.16%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 9.83 +0.06	6/12/2024	₹ 112.33	-	-	-	-1.70%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 9.81 +0.04	27/12/2024	₹ 331.04	-	-	-	-1.95%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 9.77 +0.03	27/6/2025	₹ 637.36	-	-	-	-2.30%
LIC MF Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 29.38 +0.08	28/2/2019	₹ 88.29	0.40%	19.83%	14.77%	17.93%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.31 +0.06	8/11/2021	₹ 226.89	-2.59%	20.99%	-	13.59%
Mirae Asset Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 38.89 +0.31	2/7/2018	₹ 2,908.21	0.94%	21.45%	19.07%	20.78%